Preclin Biosystems
Preclin Biosystems AG is a Swiss ETH Zurich spin-off contract research organization that provides customized in vivo preclinical testing services in chronic inflammatory and infectious disease models to pharmaceutical and biotechnology clients.
- Company typePrivate
- Founded2008
- HeadquartersEpalinges, Switzerland
- Headcount1–10
- GTM typeB2B
- OfferingServices
What Preclin Biosystems does
Preclin Biosystems AG is a privately held Swiss contract research organization headquartered in Epalinges, Switzerland, that operates a comprehensive in vivo preclinical testing platform for the identification and validation of lead candidate therapeutics. Founded in 2008 as a spin-off from ETH Zurich and led by co-founder and CEO Bettina Ernst, the firm specializes in chronic inflammatory and infectious disease models, offering fully customizable services that range from basic pathogen load and clinical disease scoring through to cellular and molecular readouts of drug efficacy, mechanism of action studies, safety assessment, and microbiome analysis.
The company's core product is its proprietary portfolio of validated animal models covering viral (Influenza A, RSV, neonatal RSV, human metapneumovirus, LCMV, Vaccinia), bacterial (Streptococcus pneumoniae, Staphylococcus aureus, Klebsiella pneumoniae, Pseudomonas aeruginosa, Listeria monocytogenes, post-influenza pneumonia), parasitic (Heligmosomoides polygyrus, Leishmania major), and chronic inflammatory indications (atopic asthma, neutrophilic asthma, COPD, pulmonary fibrosis, atopic dermatitis, psoriasis, eosinophilic esophagitis, collagen-induced arthritis, EAE, idiopathic pneumonia syndrome). Service delivery is executed by a small team of 1–10 employees with deep domain expertise.
Commercially, Preclin Biosystems operates as a B2B professional services CRO with a sales-led, consultative go-to-market. Pricing is fully customized per project with no publicly disclosed tiers, and customer engagement is driven by direct email outreach and presence at major international partnering conferences (Bio-Europe, BIO International Convention). The customer base consists of pharmaceutical and biotechnology companies requiring preclinical efficacy and safety data to support lead candidate advancement toward IND-enabling studies, with testimonial evidence indicating repeat engagement and high satisfaction among enterprise pharma/biotech R&D teams.
Preclin Biosystems firmographics
Firmographics- Name
- Preclin Biosystems
- Legal name
- Preclin Biosystems AG
- Website
- https://preclinbiosystems.com
- Company type
- Private
- Founded year
- 2008
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- Preclin Biosystems AG is a Swiss ETH Zurich spin-off contract research organization that provides customized in vivo preclinical testing services in chronic inflammatory and infectious disease models to pharmaceutical and biotechnology clients.
- Ownership category
- akta.pro rank
Preclin Biosystems industry classification
Industry- Product category
- Preclinical Contract Research Services
- NAICS
- Scientific Research and Development Services (5417), Research and Development in Biotechnology (except Nanobiotechnology) (541714)
- SIC
- Services-Commercial Physical & Biological Research (8731)
- akta.pro primary industry
- Preclinical CROs (Discovery/Pharmacology/DMPK) (HLAGAAAB)
- akta.pro secondary industry
- Preclinical Development (Pharmacology, PK/PD, ADME, Toxicology) (HLAIALAC)
Keywords
Where Preclin Biosystems is headquartered
LocationHeadquarters
- HQ city
- Epalinges
- HQ country
- Switzerland
- HQ region
- Europe
Offices1 record
Markets served
Preclin Biosystems business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales
Revenue model
- Preclinical Contract Research Services: The company provides customized preclinical testing services for pharmaceutical and biotech companies, offering study design, execution, and reporting for drug efficacy and safety evaluation in animal models. Services range from basic pathogen load assessments to complex cellular and molecular readouts.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Multi-year contract | Fully customized service packages |
Go-to-market motion2 records
Distribution channels1 record
Marketing channels2 records
Preclin Biosystems product offering
Product offeringCore offering
Preclin Biosystems AG operates a comprehensive in vivo preclinical testing platform that supports pharmaceutical and biotechnology companies in the identification and validation of lead candidate therapeutics. The company specializes in chronic inflammatory and infectious disease models, offering fully customizable services ranging from basic pathogen load and disease clinical scores to advanced cellular and molecular readouts of drug efficacy, mechanism of action studies, optimal route/regime of administration, and safety assessment.
Product overview
Preclin Biosystems AG operates a single unified in vivo preclinical testing platform for drug discovery and development. The platform offers specialized disease model categories including viral, bacterial, parasite/protozoan, lung disease/inflammation, and autoimmune models, complemented by mechanism of action studies, safety assessment, microbiome analysis, and high-throughput in vitro screening services. All services are fully customizable, ranging from basic pathogen load/disease clinical scores to cellular and molecular readouts of drug efficacy.
Differentiator
Problem solved
Functional benefit
Products and services
- In Vivo Preclinical Testing Platform Comprehensive in vivo preclinical testing platform for identification and validation of lead candidate therapeutics, specializing in chronic inflammatory and infectious disease models with fully customizable services for pharmaceutical and biotech clients.
- Viral Disease Models
Quantifiable outcome
- Professional, reliable, and rapid preclinical drug testing services
- +1 more outcomes
Companies that use Preclin Biosystems
Customer profileNamed customers5 records
Segments4 records
Ideal customer profiles2 records
Preclin Biosystems technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature7 records
Preclin Biosystems partnerships and signals
Strategic signalScale indicators2 records
Recent moves4 records
Expansion highlights3 records
Preclin Biosystems competitors and assessment
Company assessmentEmerging players
- GenScript: Biotech services company with preclinical and cell biology capabilities, including custom in vivo and in vitro services. Adjacent to Preclin in providing outsourced preclinical research tools and services.
- Bionova Scientific: Specialized preclinical CRO with focus on biologics and cell-based services. Comparable as a smaller specialty CRO serving biotech sponsors with outsourced preclinical capabilities.
Broad incumbents
- Wuxi AppTec: Major global CRO/CDMO with preclinical in vivo capabilities across infectious and inflammatory disease. Competes for outsourced preclinical work from biotech and pharma clients similar to Preclin's customer base.
- Charles River Laboratories: Global leader in preclinical CRO services with extensive in vivo pharmacology, infectious disease, and inflammation models. Preclin competes for the same pharma/biotech sponsors but on a far smaller, more specialized scale.
- Labcorp Drug Development (Covance): Large CRO offering preclinical in vivo services, safety assessment, and broader drug development. Overlaps with Preclin in preclinical efficacy and safety work for pharma and biotech sponsors.
- Eurofins Scientific: Large contract laboratory services provider with preclinical and bioanalytical offerings. Overlaps with Preclin in providing outsourced scientific research services to pharma/biotech clients.
Direct peers
- Pharmaron: Integrated CRO with preclinical in vivo pharmacology and safety assessment capabilities. Competes for outsourced preclinical programs from pharma and biotech clients similar to Preclin's.
- Inotiv: Preclinical CRO offering in vivo pharmacology, toxicology, and disease models. Provides comparable outsourced preclinical research services to pharma and biotech sponsors.
- Crown Bioscience: Preclinical CRO specializing in oncology and inflammation models with in vivo efficacy and translational services. Closely comparable in business model and customer base to Preclin Biosystems.
- Evotec: Contract research organization with deep preclinical capabilities including inflammation and infectious disease models. Direct competitor for outsourced in vivo efficacy, mechanism of action, and translational studies.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat3 records
Key risks6 records
Key highlights6 records
Customer concentration
Preclin Biosystems social profiles
Digital presencePreclin Biosystems financial estimates
Financial estimateRevenue estimate
Valuation estimate
Preclin Biosystems leadership team
Management profileNumber of profiles
Profiles1 record
Preclin Biosystems funding detail
Funding detailFunding overview
Funding rounds3 records
Investors1 record
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Preclin Biosystems M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Preclin Biosystems
What does Preclin Biosystems do?
Preclin Biosystems AG operates a comprehensive in vivo preclinical testing platform that supports pharmaceutical and biotechnology companies in the identification and validation of lead candidate therapeutics. The company specializes in chronic inflammatory and infectious disease models, offering fully customizable services ranging from basic pathogen load and disease clinical scores to advanced cellular and molecular readouts of drug efficacy, mechanism of action studies, optimal route/regime of administration, and safety assessment.
Is Preclin Biosystems a public or private company?
Preclin Biosystems is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Preclin Biosystems founded?
Preclin Biosystems was founded in 2008. It employs 1 to 10 people.
Where is Preclin Biosystems based?
Preclin Biosystems is headquartered in Epalinges, Switzerland, in the Europe region.
How does Preclin Biosystems make money?
One revenue line is on record: preclinical Contract Research Services.
Who are Preclin Biosystems's main competitors?
Emerging players on record are GenScript and Bionova Scientific. Broad incumbents are Wuxi AppTec, Charles River Laboratories, Labcorp Drug Development (Covance) and Eurofins Scientific. Direct peers are Pharmaron, Inotiv, Crown Bioscience and Evotec.
Does Preclin Biosystems have an API?
No public API is recorded for Preclin Biosystems.
What industry is Preclin Biosystems in?
Preclin Biosystems's product category is Preclinical Contract Research Services. Its primary akta.pro industry code is HLAGAAAB, Preclinical CROs (Discovery/Pharmacology/DMPK), with a secondary code of HLAIALAC, Preclinical Development (Pharmacology, PK/PD, ADME, Toxicology). Its NAICS code is 5417 and its SIC code is 8731.